Home / Health / Amid concerns over effectiveness, govt ramping up Remdesivir production

Amid concerns over effectiveness, govt ramping up Remdesivir production

Remdesivir may soon be dropped from ICMR's Covid treatment protocol, as experts have questioned its effectiveness in Covid treatment.

Premium

A man holds boxes of Remdesivir, an antiviral drug used to treat Covid-19 coronavirus symptoms, purchased from a government dispensary, in Chennai (Photo: PTI)

BS Web Team

2 min read Last Updated : May 19 2021 | 5:25 PM IST

The Indian government, on Wednesday, claimed it has ramped up the production of Remdesivir, an anti-viral drug prescribed for treating moderate-to-critical Covid patients, by 10 times. From 1 million vials per month in April, the Centre claims it will produce 10 million vials this month, as it has increased the number of plants manufacturing Remdesivir from 20 to 60.

Meanwhile, reports suggest that Remdesivir may soon be dropped from the Indian Council of Medical Research’s Covid treatment protocol, as experts have questioned its effectiveness in Covid treatment. The news comes just days after plasma therapy was dropped from ICMR’s Covid

Topics : Coronavirus Remdesivir ICMR

What you get on BS Premium?

Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
Pick your 5 favourite companies, get a daily email with all news updates on them.
Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
Preferential invites to Business Standard events.
Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.

VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in